Clinical use of prostate specific antigen in patients with prostate cancer.

The Journal of Urology
M A HudsonWilliam J Catalona

Abstract

The clinical use of prostate specific antigen as a screening test for prostate cancer, as a preoperative determinant for staging of prostate cancer and to monitor response to therapy in prostatic cancer patients was evaluated in 168 men with benign prostatic hyperplasia and 231 men with prostate cancer. Only 3% of the men with benign prostatic hyperplasia had prostate specific antigen levels greater than 10 ng. per ml. compared to 44% of the men with proved prostate cancer. Preoperative prostate specific antigen levels increased with higher clinical stages of prostate cancer but there was substantial overlap among stages. Among patients with stage A1 prostate cancer who were followed expectantly none had an elevated prostate specific antigen value or metastatic disease during a followup of 15 to 120 months. After radical prostatectomy serum prostate specific antigen values decreased to undetectable levels (less than 0.6 ng. per ml.) in 89% of the patients with organ-confined disease, in 87% of those with microscopically positive margins only but in only 34% with seminal vesicles or lymph node involvement. Failure of the prostate specific antigen levels to decrease to the undetectable range after radical prostatectomy was associ...Continue Reading

References

May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K W WattR Loor
Oct 8, 1987·The New England Journal of Medicine·T A StameyE Redwine
Jan 1, 1981·The Prostate·M C WangT M Chu
Jul 1, 1938·The Journal of Clinical Investigation·A B Gutman, E B Gutman

❮ Previous
Next ❯

Citations

Jul 1, 1992·Cancer·J D Schmidt
Nov 1, 1992·The Journal of Urology·T K TakayamaP H Lange
Nov 1, 1994·The Journal of Urology·A W Partin, J E Oesterling
Oct 16, 1999·Medical Decision Making : an International Journal of the Society for Medical Decision Making·P L ChangK H Tsui
Oct 7, 2000·Annals of Nuclear Medicine·N O KüçükA Soylu
Dec 20, 2005·International Urology and Nephrology·Hatzimouratidis Konstantinos
Jan 14, 2016·Environmental Science and Pollution Research International·Xian Liang SunLe Ke Son
Feb 23, 2020·Nature Reviews. Urology·Anthony J Costello
Jan 1, 1991·Acta Oncologica·M K Brawer
Mar 1, 1992·The Journal of Urology·M I Resnick
Jan 1, 1991·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·E H Cooper
Mar 1, 1992·The Journal of Urology·M K BrawerP H Lange
Dec 15, 1993·Cancer·H MatzkinM S Soloway
Mar 1, 1994·International Journal of Urology : Official Journal of the Japanese Urological Association·M YamamotoK Miyake

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.